Semaglutide Shows Promise in NASH Phase 2 Study Semaglutide Shows Promise in NASH Phase 2 Study

"This bodes well for further study of semaglutide and is supported further by marked improvements in weight, glycemic control and lipid profile."Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Internal Medicine News Source Type: news